|
US20030032788A1
(en)
|
1997-07-03 |
2003-02-13 |
Thomas Jefferson University |
Methods of inhibiting alcohol consumption
|
|
ATE338139T1
(de)
*
|
1999-08-30 |
2006-09-15 |
Wisconsin Alumni Res Found |
Herstellung von 3-hydroxypropionsäure in rekombinanten organismen
|
|
KR20080023768A
(ko)
|
2000-03-30 |
2008-03-14 |
화이트헤드 인스티튜트 포 바이오메디칼 리서치 |
Rna 간섭의 rna 서열 특이적인 매개체
|
|
CN100523215C
(zh)
|
2000-12-01 |
2009-08-05 |
马普科技促进协会 |
介导rna干涉的小rna分子
|
|
US20050159378A1
(en)
|
2001-05-18 |
2005-07-21 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)
|
|
US20050019915A1
(en)
|
2001-06-21 |
2005-01-27 |
Bennett C. Frank |
Antisense modulation of superoxide dismutase 1, soluble expression
|
|
WO2003040395A2
(en)
|
2001-11-07 |
2003-05-15 |
Applera Corporation |
Universal nucleotides for nucleic acid analysis
|
|
EP2305813A3
(en)
*
|
2002-11-14 |
2012-03-28 |
Dharmacon, Inc. |
Fuctional and hyperfunctional sirna
|
|
US20070265220A1
(en)
|
2004-03-15 |
2007-11-15 |
City Of Hope |
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
|
|
WO2005116265A2
(en)
|
2004-05-26 |
2005-12-08 |
Wyeth |
Probe arrays for expression profiling of rat genes
|
|
WO2007030167A1
(en)
|
2005-09-02 |
2007-03-15 |
Nastech Pharmaceutical Company Inc. |
Modification of double-stranded ribonucleic acid molecules
|
|
WO2010033225A2
(en)
|
2008-09-22 |
2010-03-25 |
Dicerna Pharmaceuticals, Inc. |
Compositions and methods for the specific inhibition of gene expression by dsrna possessing modifications
|
|
WO2010039543A2
(en)
|
2008-09-23 |
2010-04-08 |
Traversa Therapeutics, Inc. |
Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference
|
|
KR20110110776A
(ko)
|
2008-12-18 |
2011-10-07 |
다이서나 파마수이티컬, 인크. |
유전자 발현의 특이적 억제를 위한 연장된 다이서 기질 제제 및 방법
|
|
WO2010093788A2
(en)
|
2009-02-11 |
2010-08-19 |
Dicerna Pharmaceuticals, Inc. |
Multiplex dicer substrate rna interference molecules having joining sequences
|
|
US8927513B2
(en)
|
2009-07-07 |
2015-01-06 |
Alnylam Pharmaceuticals, Inc. |
5′ phosphate mimics
|
|
US9725479B2
(en)
|
2010-04-22 |
2017-08-08 |
Ionis Pharmaceuticals, Inc. |
5′-end derivatives
|
|
KR20120005240A
(ko)
|
2010-07-08 |
2012-01-16 |
한양대학교 산학협력단 |
제2알데하이드 탈수소효소의 발현을 억제하는 인공 마이크로 rna 및 이의 이용
|
|
CA2850792A1
(en)
*
|
2011-10-05 |
2013-04-11 |
Protiva Biotherapeutics Inc. |
Compositions and methods for silencing aldehyde dehydrogenase
|
|
AU2012328680A1
(en)
|
2011-10-25 |
2014-05-01 |
Ionis Pharmaceuticals, Inc. |
Antisense modulation of GCCR expression
|
|
EP2928877B1
(en)
|
2012-12-06 |
2020-01-22 |
Merck Sharp & Dohme Corp. |
Disulfide masked prodrug compositions and methods
|
|
EP3140651B1
(de)
|
2014-05-09 |
2022-10-26 |
Oncimmune Germany GmbH |
Markersequenzen zur diagnose und stratifizierung von systemische sklerose patienten
|
|
CN107109405A
(zh)
|
2014-06-06 |
2017-08-29 |
索尔斯蒂斯生物有限公司 |
具有生物可逆性和非生物可逆性基团的多核苷酸构建体
|
|
EP3865576A1
(en)
*
|
2014-12-15 |
2021-08-18 |
Dicerna Pharmaceuticals, Inc. |
Ligand-modified double-stranded nucleic acids
|
|
US10689647B2
(en)
*
|
2015-05-08 |
2020-06-23 |
Dicerna Pharmaceuticals, Inc. |
Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA
|
|
MX2019002075A
(es)
|
2016-08-23 |
2019-07-01 |
Dicerna Pharmaceuticals Inc |
Composiciones que comprenden oligonucleotidos modificados reversiblemente, y sus usos.
|
|
WO2018045317A1
(en)
|
2016-09-02 |
2018-03-08 |
Dicerna Pharmaceuticals, Inc. |
4'-phosphate analogs and oligonucleotides comprising the same
|
|
IL269517B2
(en)
|
2017-04-05 |
2025-01-01 |
Silence Therapeutics Gmbh |
Nucleic acids for inhibiting expression of a target gene in a cell, conjugates thereof, compositions containing them, and medical uses thereof
|
|
US11015198B2
(en)
|
2017-04-05 |
2021-05-25 |
Silence Therapeutics Gmbh |
Products and compositions
|
|
HRP20231063T1
(hr)
|
2017-10-13 |
2023-12-22 |
Novo Nordisk Health Care Ag |
Postupci i pripravci namijenjeni inhibiranju eksprimiranja ldha
|
|
WO2019092282A1
(en)
|
2017-11-13 |
2019-05-16 |
Silence Therapeutics Gmbh |
Nucleic acids for inhibiting expression of aldh2 in a cell
|
|
CN119120476A
(zh)
|
2017-11-13 |
2024-12-13 |
赛伦斯治疗有限责任公司 |
用于抑制细胞中lpa的表达的核酸
|
|
EP3710588A4
(en)
|
2018-01-16 |
2021-08-18 |
Dicerna Pharmaceuticals, Inc. |
COMPOSITIONS AND METHODS TO INHIBIT ALDH2 EXPRESSION
|
|
AU2020252560A1
(en)
|
2019-04-04 |
2021-10-28 |
Dicerna Pharmaceuticals, Inc. |
Compositions and methods for inhibiting gene expression in the central nervous system
|
|
TW202233839A
(zh)
|
2020-11-13 |
2022-09-01 |
美商戴瑟納製藥股份有限公司 |
用於抑制aldh2表現之化學修飾
|